Obermatt
See Similar Stocks →

Drugs Made In America Acquisition

NMQ:DMAA · KYG2847J1040
Capital MarketsX-Small

360° View

no current rank
Price/Sales—
Price/Earnings81
Price/Book17
Dividend Yield1
Revenue Growth—
Profit Growth42
Capital Growth32
TSR 52w81
Leverage31
Liquidity—
Refinancing86
Combined—
Analyst Opinions—
Pro Holdings70
Opinion Changes—
Market Pulse4

Profile

CountryUSA
IndustryCapital Markets
SizeX-Small
TypePublic Company
ExchangeNASDAQGM
Founded2024
ISINKYG2847J1040
Last UpdateApr 2, 2026

Description

Drugs Made In America Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company’s initial busin…

Similar Stocks

The companies this stock is ranked against.

Compare Drugs Made In America Acquisition with its peers
Starry Sea Acquisition
NAQ:SSEA
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Pelican Acquisition
NMQ:PELI
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Pantages Capital Acquisition
NMQ:PGAC
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Horizon Space Acquisition II
NMQ:HSPT
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Drugs Made In America Acquisition II
NMQ:DMII
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Charlton Aria Acquisition
NMQ:CHAR
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →